期刊文献+

抗菌药物优化给药方案研究进展

Research Progress in Optimized Regimens of Antibacterial Agents
下载PDF
导出
摘要 抗菌药物通过优化应用获得最强的抗菌活性、最佳的临床效果、减少毒性以及预防耐药性的给药方案。药动学/药效学参数与临床疗效密切相关,并从其角度考虑各种情况下包括病理生理状态下剂量选择,从药物毒性角度确定用药方案。重视普通敏感菌感染、耐药菌感染或严重感染患者不同剂量和方案的选择,重症患者重视负荷剂量。优化给药方案尚是不断探索、实践、完善的过程,基于耐药机制、联用的具体方案、群体药代动力学模型等研究是新趋势。 Through optimization of the application, the strongest antibacterial activity, best clinical efficacy, drug toxicity reduction and to drug resistance prevention can be achieved. The parameters of pharmacokinetics/pharmacodynamics are closely related to the clinical effect, and the choice of dosage should be considered from its point of view under various conditions including physiological and pathological condition, and the medication regimens should be determined from drug toxicity. The selection of different doses and regimens for patients with ordinary bacterial infection, resistant bacteria infection, or severe infection should be paid due attention, and loading dose should be considered in critically ill patients. Optimization of the prescription is still in the process of exploring, practicing and improving, and the specific programs based on the mechanism of drug resistance and combination, and the population pharmacokinetic model, are the new trend in th, field.
出处 《医学综述》 2016年第2期304-309,共6页 Medical Recapitulate
关键词 抗菌药物 药动学/药效学 抗菌活性 给药方案优化 临床疗效 Antibacterial drugs Pharmacokinetics/pharmacodynamics Antibacterial activity Optimi zation of medication Clinical curative effect
  • 相关文献

参考文献36

  • 1Eagle H,Fleischman R,Musselman AD.Effect of schedule of administration on the therapeutic efficacy of penicillin;importance of the aggregate time penicillin remains at effectively bactericidal levels[J].Am J Med,1950,9(3):280-299.
  • 2Craig WA.Pharmacokinetic/pharmacodynamic parameters:rationale for antibacterial dosing of mice and men[J].Clin Infect Dis,1998,26(1):1-10.
  • 3Shah PM,Junghanns,Stille W.Bactericidal dosie-activity relationships with E.coli,K.pneumoniae and Staph.aureus(author's transl)[J].Dtsch Med Wochenschr,1976,101(9):325-328.
  • 4Kuti JL,Nicolau DP.Making the most of surveillance studies:summary of the OPTAMA Program[J].Diagn Microbiol Infect Dis,2005,53(4):281-287.
  • 5Owens RC Jr,Am brose PG,Nightingale CH.Antibiotic Optimization.Concepts and strategies in clinical practice[M].New York:Marced Dekker,2005:491-518.
  • 6汪复,张婴元.实用抗感染治疗学[M].2版.北京:人民卫生出版神.2013:156.
  • 7Mouton JW,Ambrose PG,Canton R,et al.Conserving antibiotics for the future:new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective[J].Drug Resist Updat,2011,14(2):107-117.
  • 8肖永红.抗菌药物药代动力学/药效学与医院肺炎的优化治疗[J].实用医院临床杂志,2013,10(4):1-4. 被引量:14
  • 9王瑾,白艳,张丹丹,王睿.喹诺酮类抗菌药物PK/PD研究进展[J].中国药学杂志,2014,49(9):786-789. 被引量:6
  • 10王江峰,范辉.抗真菌药的PK/PD研究和临床用药优化[J].中国药房,2013,24(22):2094-2097. 被引量:4

二级参考文献171

共引文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部